•  
  •  
  •  
  •  

2026-02-09 00:54:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • KSH International Q3 & 9M FY26: Record Revenue +59% YoY to ₹818 Cr, EBITDA +23%; Capacity Hits 43K MT
  • Advance Agrolife Q3 & 9M FY26: Revenue +25% YoY to ₹516 Cr, PAT +15% to ₹28 Cr Amid Expansion
  • Vidya Wires' WOS ALCU Industries Starts Commercial Production of Winding/Conductivity Products in Gujarat
  • Oswal Pumps 9M FY26: Revenue +47% YoY to ₹1,569 Cr, PAT +31% at 18% Margin on PM-KUSUM Surge
  • Sportking India Q3 & 9M FY26: PAT +33% YoY to ₹25 Cr, EBITDA +11% at 10% Margin; Greenfield Groundbreaking

Keywords Selected:  Approval

IPO News

  • VMS TMT Limited Gets SEBI Nod to Float an IPO
  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • Icon Facilitators Announces BSE SME IPO Approval, Targets ₹22 Crore Fundraise
  • Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
  • Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO
  • Senores Pharmaceuticals gets Sebi nod for IPO
  • Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO
  • IT Solutions provider Orient Technologies gets Sebi nod for IPO
  • Gala Precision Engineering gets Sebi nod for IPO
  • Noida-based Interarch Building Products Limited gets SEBI nod for IPO
  • Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO
  • Allied Blenders and Distillers Limited gets Sebi nod for Rs 1500 crore IPO
  • Sanstar Limited, gets SEBI nod to float IPO
  • Asirvad Micro Finance Limited gets Sebi nod for IPO
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Fairfax-backed Go Digit General Insurance gets Sebi nod for IPO
  • Gopal Snacks Limited gets Sebi nod for Rs 650 crore IPO
  • Juniper Hotels gets Sebi nod for its Rs 1,800 crore IPO
  • Stanley Lifestyles gets Sebi nod for IPO
  • Onest and Shiva Pharmachem gets Sebi nod for IPO
  • Mukka Proteins Limited gets Sebi Nod for IPO
  • Ludhiana-based Auto Component Maker Happy Forgings Limited receives Sebi nod to float its IPO
  • Cello World Limited gets Sebi nod for its Rs 1750 crore IPO
  • ESAF Small Finance Bank gets Sebi nod for IPO

Stock Report

  • Alembic Pharmaceuticals gets USFDA nod for generic Parkinson's disease treatment tablets
  • Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg
  • NATCO receives Tentative Approval for Erdafitinib Tablets from USFDA
  • SPARC announces receipt of Priority Review Voucher associated with Sezaby® Approval
  • Epic Renewable Projects Pvt Ltd receives approvals for 2.70 MWh Solar Power Project
  • Pine Labs Ltd receives RBI nod for acquisition of 100% stake in Agya Technologies
  • Medicamen Biotech Ltd gets EU approval for Paracetamol from Danish Medicine Authority
  • Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
  • The Ramco Cements Ltd receives approval from Government of Andhra Pradesh
  • Dixon Technologies India Ltd's subsidiaries granted approval by MeitY under ECMS
  • KPI Green Energy Ltd receives charging approval for 32.40 MW of solar and hybrid power projects
  • Caplin acquires 10 approves ANDAs injection and Opthalmic products
  • Oriental Foundry Pvt Ltd receives approval for registration as Wagon Leasing Company
  • Cupid Ltd to set up FMCG Manufacturing Facility in Saudi Arabia
  • Leo Dry Fruits & Spices Trading Ltd receives AGMARK approval
  • AGI Infra Ltd obtains RERA, Punjab approval for 'Urbana Square'
  • Granules Pharmaceuticals Inc. receives FDA tentative approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004%
  • Titan Intech Ltd gets in-principle approval for term loan from IDBI Bank Limited
  • RBI gives nod to HDFC Bank Group for investment of upto 9.5% in IndusInd bank
  • Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%
  • Neetu Yoshi Ltd receives approval for registration from RDSO
  • Caplin Steriles gets USFDA approval for Linezolid Injection, Infusion bags

Industry News

  • Ashika Investment Managers Launches SmartAlpha Fund, a New Open-Ended Category III Data Strategy Fund
  • RBI grants NBFC license to Equirus Group
  • NCLT approves slice and North East Small Finance Bank's Merger
  • NSE launches WTI Crude Oil and Natural Gas futures contracts
  • Zero To One, an angel network, gets SEBI nod to launch INR 300cr Alternative Investment Fund
  • Pre Construction Tips: Things to Check
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license
  • Insurance product approvals made easy - Steps towards ease of doing business

Latest Post

  • KSH International Q3 & 9M FY26: Record Revenue +59% YoY to ₹818 Cr, EBITDA +23%; Capacity Hits 43K MT
  • Advance Agrolife Q3 & 9M FY26: Revenue +25% YoY to ₹516 Cr, PAT +15% to ₹28 Cr Amid Expansion
  • Vidya Wires' WOS ALCU Industries Starts Commercial Production of Winding/Conductivity Products in Gujarat
  • Oswal Pumps 9M FY26: Revenue +47% YoY to ₹1,569 Cr, PAT +31% at 18% Margin on PM-KUSUM Surge
  • Sportking India Q3 & 9M FY26: PAT +33% YoY to ₹25 Cr, EBITDA +11% at 10% Margin; Greenfield Groundbreaking


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025